Pharmacy News

How to talk to patients about the J&J vaccine

Patients will be coming to pharmacists with questions and concerns as the recommendation to suspend use of the Janssen (Johnson & Johnson, J&J) vaccine remains in place.

DOACs seem to outperform warfarin for patients with valvular AF

Direct oral anticoagulants (DOACs) are associated with better outcomes than warfarin among patients with valvular atrial fibrillation (AF), according to a study published on March 30, 2021 in the Annals of Internal Medicine.

New NEJM article can serve as diabetes medication resource

The list of medication options to treat patients who have diabetes grows continually longer and longer. A new clinical practice review article published April 1 by Rita Rastogi Kalyani, MD, in The New England Journal of Medicine (NEJM), distills the newest trial results and guidelines into a systematic approach for the treatment of patients with diabetes.

Shorter courses of antibiotics for patients, say new guidelines

New clinical guidelines promote shorter courses of antibiotics for the treatment of uncomplicated cases of pneumonia, urinary tract infection, cellulitis, COPD exacerbations, and acute bronchitis, according to updated recommendations from the American College of Physicians.

CDC adds new conditions to COVID-19 high-risk list

On March 29, CDC revised its list of conditions that put an individual at high risk for severe COVID-19 disease, meaning the patient may require hospitalization, intensive care, a ventilator to help with breathing, or could even die.